Literature DB >> 17185786

Diagnostic criteria for polycystic ovarian syndrome.

F J Broekmans1, B C J M Fauser.   

Abstract

Until recently no universally accepted clinical definition existed for the polycystic ovary syndrome (PCOS). What has emerged from research over the last 30 yr is a profound heterogeneity and ongoing speculation regarding etiology. The various symptoms and signs related to PCOS have now been extensively evaluated as to their possible contribution to the diagnosis. Consensus has been reached for the use of oligomenorrhea or amenorrhea, clinical or biochemical hyperandrogenism, and polycystic ovaries at ultrasound as key diagnostic criteria. Obesity, insulin resistance, and the so-called metabolic syndrome should be recognized as associated conditions that present long-term health risks for diagnosed PCOS cases. The way all these features need to be applied in the work up of the individual index patient is reviewed here.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185786     DOI: 10.1385/ENDO:30:1:3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  103 in total

1.  Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives.

Authors:  R R Tremblay; J Y Dube
Journal:  Contraception       Date:  1974-12       Impact factor: 3.375

Review 2.  Pregnancy complications in PCOS.

Authors:  Roy Homburg
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-06       Impact factor: 4.690

Review 3.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

4.  Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

5.  Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

Authors:  B Imani; M J Eijkemans; F H de Jong; N N Payne; P Bouchard; L C Giudice; B C Fauser
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

Review 6.  Polycystic ovary syndrome.

Authors:  V T Goudas; D A Dumesic
Journal:  Endocrinol Metab Clin North Am       Date:  1997-12       Impact factor: 4.741

7.  Defects in beta-cell function in functional ovarian hyperandrogenism.

Authors:  N M O'Meara; J D Blackman; D A Ehrmann; R B Barnes; J B Jaspan; R L Rosenfield; K S Polonsky
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

Review 8.  The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

Authors:  Sophie Jonard; Didier Dewailly
Journal:  Hum Reprod Update       Date:  2004 Mar-Apr       Impact factor: 15.610

9.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

Authors:  Pascal Pigny; Emilie Merlen; Yann Robert; Christine Cortet-Rudelli; Christine Decanter; Sophie Jonard; Didier Dewailly
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

10.  Components of the "metabolic syndrome" and incidence of type 2 diabetes.

Authors:  Robert L Hanson; Giuseppina Imperatore; Peter H Bennett; William C Knowler
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

View more
  12 in total

1.  Autoantibodies to mesothelin in infertility.

Authors:  Judith L Luborsky; Yi Yu; Seby L Edassery; Jade Jaffar; Yuan Yee Yip; Pu Liu; Karl Eric Hellstrom; Ingegerd Hellstrom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-16       Impact factor: 4.254

2.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

Review 3.  Energy metabolism and fertility: a balance preserved for female health.

Authors:  Sara Della Torre; Valeria Benedusi; Roberta Fontana; Adriana Maggi
Journal:  Nat Rev Endocrinol       Date:  2013-10-22       Impact factor: 43.330

4.  Anti-HE4 antibodies in infertile women and women with ovarian cancer.

Authors:  Ingegerd Hellstrom; Elizabeth Swisher; Karl Erik Hellstrom; Yuen Yee Yip; Kathy Agnew; Judith L Luborsky
Journal:  Gynecol Oncol       Date:  2013-05-28       Impact factor: 5.482

5.  Polycystic Ovarian Syndrome-associated Confluent and Reticulated Papillomatosis: Report of a Patient Successfully Treated with Azithromycin.

Authors:  Laura Paul Fite; Philip R Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

6.  The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment.

Authors:  Carrie C Dennett; Judy Simon
Journal:  Diabetes Spectr       Date:  2015-05

7.  The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome.

Authors:  Mohammad Ehsan Rahiminejad; Amirhossein Moaddab; Soghra Rabiee; Farzaneh Esna-Ashari; Shiva Borzouei; Seyyed Mohammad Hosseini
Journal:  Iran J Reprod Med       Date:  2014-12

Review 8.  Peroxisome Proliferator-Activated Receptors in Female Reproduction and Fertility.

Authors:  Maurizio Vitti; Giovanna Di Emidio; Michela Di Carlo; Gaspare Carta; Andrea Antonosante; Paolo Giovanni Artini; Annamaria Cimini; Carla Tatone; Elisabetta Benedetti
Journal:  PPAR Res       Date:  2016-07-31       Impact factor: 4.964

9.  Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.

Authors:  Irene Cimino; Filippo Casoni; Xinhuai Liu; Andrea Messina; Jyoti Parkash; Soazik P Jamin; Sophie Catteau-Jonard; Francis Collier; Marc Baroncini; Didier Dewailly; Pascal Pigny; Mel Prescott; Rebecca Campbell; Allan E Herbison; Vincent Prevot; Paolo Giacobini
Journal:  Nat Commun       Date:  2016-01-12       Impact factor: 14.919

10.  Leptin and body mass index in polycystic ovary syndrome.

Authors:  Nasrin Jalilian; Lida Haghnazari; Samira Rasolinia
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.